Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis
Abstract Context In 2015, the updated Prostate Imaging Reporting and Data System version
2 (PI-RADSv2) for the detection of prostate cancer (PCa) was established. Since then …
2 (PI-RADSv2) for the detection of prostate cancer (PCa) was established. Since then …
Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta …
Context The variability of the positive predictive value (PPV) represents a significant factor
affecting the diagnostic performance of multiparametric magnetic resonance imaging …
affecting the diagnostic performance of multiparametric magnetic resonance imaging …
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a histopathology gold standard in the detection, intraprostatic localization, and determination of …
The role of prostate-specific membrane antigen (PSMA)–targeted PET in comparison to
multiparametric MRI (mpMRI) in the evaluation of intraprostatic cancer foci is not well …
multiparametric MRI (mpMRI) in the evaluation of intraprostatic cancer foci is not well …
Prospective evaluation of PI-RADS™ version 2 using the international society of urological pathology prostate cancer grade group system
S Mehralivand, S Bednarova, JH Shih… - The Journal of …, 2017 - auajournals.org
Purpose: The PI-RADS™(Prostate Imaging Reporting and Data System), version 2 scoring
system, introduced in 2015, is based on expert consensus. In the same time frame ISUP …
system, introduced in 2015, is based on expert consensus. In the same time frame ISUP …
A systematic review of the existing prostate imaging reporting and data system version 2 (PI-RADSv2) literature and subset meta-analysis of PI-RADSv2 categories …
EJ Barkovich, PR Shankar… - American Journal of …, 2019 - Am Roentgen Ray Soc
OBJECTIVE. The objective of this study was to quantitatively and qualitatively assess the
methodologic heterogeneity of the current Prostate Imaging Reporting and Data System …
methodologic heterogeneity of the current Prostate Imaging Reporting and Data System …
Magnetic resonance imaging radiomics‐based machine learning prediction of clinically significant prostate cancer in equivocal PI‐RADS 3 lesions
SJ Hectors, C Chen, J Chen, J Wang… - Journal of Magnetic …, 2021 - Wiley Online Library
Background While Prostate Imaging Reporting and Data System (PI‐RADS) 4 and 5 lesions
typically warrant prostate biopsy and PI‐RADS 1 and 2 lesions may be safely observed, PI …
typically warrant prostate biopsy and PI‐RADS 1 and 2 lesions may be safely observed, PI …
[HTML][HTML] Randomized clinical trials of artificial intelligence in medicine: why, when, and how?
1Department of Radiology and Research Institute of Radiology, Asan Medical Center,
University of Ulsan College of Medicine, Seoul, Korea; 2Department of Radiology, Seoul St …
University of Ulsan College of Medicine, Seoul, Korea; 2Department of Radiology, Seoul St …
Risk of clinically significant prostate cancer associated with prostate imaging reporting and data system category 3 (equivocal) lesions identified on multiparametric …
AD Sheridan, SK Nath, JS Syed… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The objective of this study is to determine the frequency of clinically significant
cancer (CSC) in Prostate Imaging Reporting and Data System (PI-RADS) category 3 …
cancer (CSC) in Prostate Imaging Reporting and Data System (PI-RADS) category 3 …
Risk stratification among men with prostate imaging reporting and data system version 2 category 3 transition zone lesions: is biopsy always necessary?
ER Felker, SS Raman, DJ Margolis… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to determine the clinical and MRI characteristics
of clinically significant prostate cancer (PCA)(Gleason score≥ 3+ 4) in men with Prostate …
of clinically significant prostate cancer (PCA)(Gleason score≥ 3+ 4) in men with Prostate …
Apparent diffusion coefficient (ADC) ratio versus conventional ADC for detecting clinically significant prostate cancer with 3-T MRI
OBJECTIVE. The purpose of this study is to evaluate the performance of the apparent
diffusion coefficient ratio (ADCratio; the ADC of the suspected prostate cancer [PCa] focus …
diffusion coefficient ratio (ADCratio; the ADC of the suspected prostate cancer [PCa] focus …